OseltamivirStevens-Johnson syndrome and toxic epidermal necrolysis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1758卷 / 1期

关键词：

D O I：

10.1007/s40278-019-63811-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：265 / 265

相关论文

共 50 条

[31] GemcitabineStevens-Johnson syndrome/toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2003, 978 (1) : 13 - 13
[32] OxcarbazepineStevens Johnson syndrome/toxic epidermal necrolysis overlap: case report
[J]. Reactions Weekly, 2016, 1619 (1) : 143 - 143
[33] LamotrigineStevens-Johnson syndrome/toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2019, 1767 (1) : 201 - 201
[34] MeropenemStevens-Johnson syndrome/toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2019, 1772 (1) : 211 - 211
[35] CotrimoxazoleStevens-Johnson syndrome/toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2017, 1657 (1) : 145 - 145
[36] Ketorolac/naproxenStevens Johnson syndrome/toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2018, 1728 (1) : 207 - 207
[37] CarbamazepineStevens-Johnson syndrome and toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2011, 1352 (1) : 14 - 14
[38] RituximabStevens-Johnson syndrome/toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2012, 1404 (1) : 36 - 36
[39] FluconazoleStevens Johnson syndrome with evolution to toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2017, 1662 (1) : 178 - 178
[40] PembrolizumabStevens-Johnson syndrome and toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2021, 1885 (1) : 441 - 441

← 1 2 3 4 5 →